Treatment of Latent Tuberculosis Infection
Author:
Affiliation:
1. From Institute for Global Health, University College London; Public Health England; and Royal Free London National Health Service Foundation Trust, London, United Kingdom, and European Centre for Disease Prevention and Control, Stockholm, Sweden.
Publisher
American College of Physicians
Subject
General Medicine,Internal Medicine
Cited by 156 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study;The Lancet Global Health;2024-09
2. Economic evaluation of diagnosis and treatment for latent tuberculosis infection among contacts of pulmonary tuberculosis patients in Thailand;Scientific Reports;2024-07-31
3. Safety and Completion of Prophylactic Treatment for Latent Tuberculosis Infection in Children;2024-06-04
4. High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial;The Lancet Respiratory Medicine;2024-06
5. Interpreter usage and associations with latent tuberculosis infection treatment acceptance and completion in the USA among non-U.S.–born persons, 2012–2017;PLOS ONE;2024-04-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3